Skip to main content
DOUBLE MEDICAL TECHNOLOGY INC. logo

DOUBLE MEDICAL TECHNOLOGY INC. — Investor Relations & Filings

Ticker · 002901 ISIN · CNE1000032W7 LEI · 836800DECKX5CGFNMD42 Shenzhen Stock Exchange Manufacturing
Open in API
Filings indexed 963 across all filing types
Latest filing 2023-08-30 Regulatory Filings
Country CN China
Listing Shenzhen Stock Exchange 002901

About DOUBLE MEDICAL TECHNOLOGY INC.

https://www.double-medical.com

Double Medical Technology Inc. specializes in the development, manufacturing, and distribution of medical devices, with a primary focus on orthopedic solutions. The company's extensive product portfolio includes trauma fixation systems, spinal implants, joint prosthesis, and neurosurgical devices. Additionally, it provides specialized surgical instruments and advanced wound care products. Double Medical emphasizes research and innovation to deliver clinically effective solutions for complex musculoskeletal conditions. Its manufacturing processes adhere to international quality standards, ensuring the reliability of its implants and instruments used in hospitals and surgical centers worldwide. The company serves a global market, providing comprehensive support for orthopedic surgeons through its diverse range of reconstructive and regenerative medical technologies.

Recent filings

Filing Released Lang Actions
关于会计政策变更的公告
Regulatory Filings Classification · 95% confidence The document is an announcement regarding a change in accounting policy by the company, detailing the reasons, the nature of the change, and approvals by the board, independent directors, and supervisory board. It does not contain financial statements or substantive financial data but rather explains the policy change and its rationale. The document length is 2026 characters, which is relatively short and consistent with an announcement rather than a full report. There is no indication that this is a full annual or interim report, audit report, or earnings release. It is a regulatory announcement about accounting policy changes, which fits best under Regulatory Filings (RNS).
2023-08-30 Chinese
2023年半年度报告摘要
Interim / Quarterly Report Classification · 95% confidence The document is titled as a '2023 半年度报告摘要' which translates to '2023 Semi-Annual Report Summary'. It contains detailed financial data such as revenue, net profit, earnings per share, and changes in accounting policies, which are typical contents of an interim or quarterly financial report. The document length is 3088 characters, which is relatively short but contains substantive financial data and analysis, not just an announcement or a link to a report. It is not a full annual report (10-K) but a half-year report, fitting the definition of an Interim / Quarterly Report (IR). There is no indication that this is merely a report publication announcement or a certification. Therefore, the appropriate classification is IR with high confidence. H1 2023
2023-08-30 Chinese
关于变更公司经营范围、修订公司章程并办理工商登记的公告
Regulatory Filings Classification · 95% confidence The document is an announcement from a company about changes to its business scope and amendments to its articles of association, including details of board resolutions and pending shareholder approval. It does not contain financial statements, audit information, or detailed financial data. It is a regulatory announcement about corporate governance and operational scope changes, not a full report or financial filing. Therefore, it fits best under Regulatory Filings (RNS), which is the fallback category for miscellaneous regulatory announcements that do not fit other specific categories.
2023-08-30 Chinese
2023年半年度财务报告
Interim / Quarterly Report Classification · 100% confidence The document is titled as a "2023 年半年度财务报告" which translates to "2023 Semi-Annual Financial Report". It contains detailed financial statements including consolidated balance sheets, profit and loss statements, cash flow statements, and equity changes for the half-year period ending June 30, 2023. The report explicitly states it is a half-year report and includes comprehensive financial data and analysis for this interim period. The document length is substantial (15,000 characters), indicating it is the full report rather than a brief announcement. There is no indication that this is an announcement of a report or a certification document. Therefore, this document fits the definition of an Interim / Quarterly Report (IR). H1 2023
2023-08-30 Chinese
半年报监事会决议公告
Regulatory Filings Classification · 95% confidence The document is a formal announcement of the resolutions passed at the fourth meeting of the third Supervisory Board of Dabao Medical Technology Co., Ltd. It includes approval of the 2023 semi-annual report and its summary, a special report on the use and storage of raised funds for the first half of 2023, and an accounting policy change. The document states that the full semi-annual report and related reports are available on the Shenzhen Stock Exchange designated information disclosure website and in newspapers, indicating this document itself is not the full semi-annual report but an announcement of the meeting resolutions and approvals. The document length is short (1331 characters), and it primarily serves as a meeting resolution announcement rather than containing substantive financial data or the full report. Therefore, it fits best under Regulatory Filings (RNS) as a general regulatory announcement and disclosure of meeting resolutions, not the actual semi-annual report (which would be an Interim/Quarterly Report IR).
2023-08-30 Chinese
关于募集资金存放与使用情况的专项报告
Capital/Financing Update Classification · 95% confidence The document is a detailed report on the use and management of funds raised through a non-public stock issuance by the company 大博医疗科技股份有限公司. It includes specifics on the amount raised, the timing of fund receipt, the use of funds, balances in special accounts, cash management activities, and compliance with regulatory requirements. The document references regulatory approvals and audit verification, and it provides a comprehensive breakdown of fund usage and project progress for the first half of 2023. This type of document is a specialized report on the status and use of capital raised, which fits the category of Capital/Financing Update (CAP). It is not an annual or interim financial report, nor is it a simple announcement or certification. The length and detail confirm it is a substantive report rather than a brief announcement or regulatory filing.
2023-08-30 Chinese

Browse filings by year

10 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.